Ads
related to: drugs, brain development
Search results
Japan's Otsuka to stop development of Alzheimer's disease drug
Reuters via AOL· 6 hours agoThe drug candidate, AVP-786, failed to show statistically significant improvement of agitation associated with Alzheimer's dementia in a late-stage study, Otsuka said. Alzheimer's ...
22-Year-Old Graduates From College After Surviving Brain Tumor, Two Major Surgeries: 'I'm Finally...
People via Yahoo News· 5 hours agoDietrich says the standard treatment for a brain tumor would be radiation and chemotherapy. But with...
Teens who use marijuana are more likely to suffer psychotic disorders, study finds
NBC News via Yahoo News· 6 hours agoTeenagers who used cannabis within the last year had a dramatically higher rate of developing a...
2 Billion More Reasons to Buy AbbVie Stock
Motley Fool via Yahoo Finance· 8 hours agoThough the area isn't traditionally in AbbVie's wheelhouse, there...biotech Gilgamesh Pharmaceuticals to collaborate on the research and development...
Risk for psychosis skyrockets among teens who use cannabis
United Press International via Yahoo News· 2 hours agoDoctors have long known that excessive marijuana use can trigger psychosis, especially in the young....
New menopause drugs treat hot flashes, but women may face insurance hurdles
NBC News via Yahoo News· 6 days agoBut doctors say insurance companies either won’t pay for them or make women try and...do with...
Simcere Phar-maceuticals Presented Six Studies on Sanbexin® at ESOC 2024
WPRI Providence· 1 day agoSanbexin®, the only Class 1 innovative drug approved worldwide since 2015, has been shown to reduce brain cell damage and dysfunction caused by ischemia ...
CNS Pharmaceuticals (NASDAQ: CNSP) CEO to Present at 2024 Healthcare Company Showcase
Digital Journal· 1 day agoThe company today announced that its Chief Executive Officer...Inc. CNS Pharmaceuticals is a clinical-stage pharmaceutical company developing a pipeline of anti-cancer drug
UNCG and A&T receive funding for research development of drugs for neurological disorders
WXII-TV Winston-Salem· 17 hours agoTwo local universities will get nearly a million dollars for research at the joint School of...
IRLAB has Administered the First Dose in a Phase I Clinical Trial with the Drug Candidate IRL757
Morningstar· 8 hours agoIRL757 has been shown in preclinical disease models to counteract apathy - a condition that impairs the quality of life for millions of people with Parkinson's disease and other CNS diseases ...
